Profund Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$377K Sell
1,680
-787
-32% -$196K 0.01% 647
2025
Q4
$594K Buy
2,467
+419
+20% +$107K 0.02% 496
2025
Q3
$561K Sell
2,048
-248
-11% -$67.7K 0.02% 475
2025
Q2
$592K Buy
2,296
+195
+9% +$46.5K 0.02% 420
2025
Q1
$470K Sell
2,101
-176
-8% -$41.1K 0.02% 495
2024
Q4
$521K Sell
2,277
-157
-6% -$37.8K 0.02% 496
2024
Q3
$594K Buy
2,434
+199
+9% +$44.5K 0.02% 463
2024
Q2
$428K Sell
2,235
-16
-0.7% -$3.25K 0.02% 551
2024
Q1
$446K Sell
2,251
-264
-10% -$48.4K 0.02% 626
2023
Q4
$433K Buy
2,515
+246
+11% +$37.8K 0.02% 590
2023
Q3
$336K Sell
2,269
-37
-2% -$6.69K 0.02% 610
2023
Q2
$504K Buy
2,306
+53
+2% +$11.8K 0.03% 509
2023
Q1
$493K Sell
2,253
-146
-6% -$31.7K 0.03% 508
2022
Q4
$499K Buy
2,399
+99
+4% +$21.8K 0.03% 417
2022
Q3
$502K Sell
2,300
-142
-6% -$32.3K 0.04% 385
2022
Q2
$512K Sell
2,442
-329
-12% -$70K 0.03% 408
2022
Q1
$672K Sell
2,771
-433
-14% -$105K 0.03% 433
2021
Q4
$835K Buy
3,204
+122
+4% +$31.7K 0.03% 383
2021
Q3
$812K Buy
3,082
+75
+2% +$20.5K 0.03% 424
2021
Q2
$740K Buy
3,007
+35
+1% +$7.36K 0.02% 466
2021
Q1
$577K Sell
2,972
-422
-12% -$84.6K 0.02% 518
2020
Q4
$721K Sell
3,394
-55
-2% -$11K 0.03% 406
2020
Q3
$591K Sell
3,449
-877
-20% -$162K 0.03% 408
2020
Q2
$831K Buy
4,326
+985
+29% +$161K 0.05% 299
2020
Q1
$492K Sell
3,341
-685
-17% -$109K 0.04% 368
2019
Q4
$624K Buy
4,026
+293
+8% +$42.2K 0.03% 518
2019
Q3
$504K Sell
3,733
-500
-12% -$65.5K 0.03% 587
2019
Q2
$517K Sell
4,233
-1,097
-21% -$122K 0.02% 613
2019
Q1
$554K Buy
5,330
+466
+10% +$48.1K 0.03% 585
2018
Q4
$554K Sell
4,864
-1,213
-20% -$130K 0.03% 442
2018
Q3
$701K Buy
6,077
+1,526
+34% +$167K 0.03% 562
2018
Q2
$471K Sell
4,551
-491
-10% -$49.7K 0.02% 829
2018
Q1
$496K Sell
5,042
-121
-2% -$11.4K 0.02% 811
2017
Q4
$437K Sell
5,163
-1,466
-22% -$121K 0.02% 888
2017
Q3
$510K Sell
6,629
-11,438
-63% -$875K 0.02% 751
2017
Q2
$1.41M Sell
18,067
-5,421
-23% -$388K 0.06% 277
2017
Q1
$1.69M Buy
23,488
+36
+0.2% +$2.49K 0.08% 237
2016
Q4
$1.46M Buy
23,452
+2,405
+11% +$147K 0.07% 260
2016
Q3
$1.36M Buy
21,047
+2,321
+12% +$154K 0.06% 275
2016
Q2
$1.18M Buy
18,726
+366
+2% +$21.6K 0.06% 318
2016
Q1
$1.06M Sell
18,360
-6,740
-27% -$381K 0.06% 325
2015
Q4
$1.35M Buy
25,100
+7,145
+40% +$403K 0.06% 255
2015
Q3
$915K Sell
17,955
-7,796
-30% -$420K 0.05% 310
2015
Q2
$1.45M Sell
25,751
-3,201
-11% -$202K 0.06% 267
2015
Q1
$2.08M Buy
28,952
+5,486
+23% +$356K 0.08% 193
2014
Q4
$1.32M Buy
23,466
+4,981
+27% +$260K 0.05% 326
2014
Q3
$911K Sell
18,485
-6,120
-25% -$312K 0.04% 419
2014
Q2
$1.25M Sell
24,605
-3,362
-12% -$167K 0.05% 371
2014
Q1
$1.25M Buy
27,967
+425
+2% +$19.1K 0.06% 357
2013
Q4
$1.3M Buy
27,542
+962
+4% +$48.7K 0.06% 354
2013
Q3
$1.4M Buy
26,580
+7,316
+38% +$355K 0.07% 272
2013
Q2
$869K Buy
+19,264
New +$914K 0.06% 326

Other funds holding RMD

Profund Advisors's RMD Position: Q1 2026 in Review

Profund Advisors reduced its ResMed (RMD) stake by 32% in Q1 2026, selling an estimated $196K and leaving 1,680 shares worth $377K. The position accounts for 0.01% of the portfolio, ranked #647.

Profund Advisors first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.08M in Q1 2015. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Profund Advisors held 1,680 shares of ResMed worth $377K as of Q1 2026.
  • Profund Advisors sold 787 ResMed shares in Q1 2026, an estimated $196K.
  • ResMed made up 0.01% of Profund Advisors's portfolio in Q1 2026, its #647 holding.
  • Profund Advisors first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • Profund Advisors's ResMed position peaked at $2.08M in Q1 2015.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.